Dr. Glass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 E 70th St
Weill Cornell Internal Medicine Associates, Box 148
New York, NY 10021Phone+1 212-746-3587Fax+1 212-746-4609
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2016
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2010 - 2012
Albert Einstein College of MedicineClass of 2010
Certifications & Licensure
NJ State Medical License 2018 - 2025
NY State Medical License 2012 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- American Board of Preventive Medicine Clinical Informatics
Publications & Presentations
PubMed
- 109 citationsClinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AMLMaximilian Stahl, Kamal Menghrajani, Andriy Derkach, Alexander Chan, Wenbin Xiao
Blood Advances. 2021-03-09 - 7 citationsInteraction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty
Blood Advances. 2023-09-12 - 18 citationsVenetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant.Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, Kamal Menghrajani, Susan DeWolf
Leukemia & Lymphoma. 2021-09-03
Abstracts/Posters
- Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent MechanismJacob L Glass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction ChemotherapyJacob L Glass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute LeukemiaJacob L Glass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- AML with Mutations in IDH1 and DNMT3A Exhibits a Distinct Epigenetic Signature with Poorer Overall Survival2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
